|

Search Results
Brand names in category Anti-Smoking:| Brand Name | Generic Name | |
|---|
| Wellbutrin SR, Zyban | Bupropion | MORE INFO |
Generic names in category Anti-Smoking:
Full Drug List
List Drugs by First Letter
Click on a letter to get a list of drug names starting with that letter:
List Drugs by Name
Enter all or part of the name of the drug you are looking for:
Contact Us
By phone, live chat, e-mail, or callback request with questions about drug availability.
New! Call our expanded customer support center toll-free at
1-866-978-4944,
7 AM - 9 PM EST Mon - Fri, 9 AM - 5 PM EST Sat - Sun.
Free Shipping!
Shipping is free regardless of destination. There are no dispensing fees, membership fees, or any other hidden fees. Orders are sent by Registered Air Mail. Delivery time to the USA is typically 10 business days after we have sent the order, though it can take longer.
FDA Drug News
MedWatch Safety Alert RSS Feed
FDA MedWatch Safety Alerts
http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/MedWatch/rss.xml
en-us
Wed, 01 Sep 2010 10:00:00 -0400
jay.wattenberg@fda.hhs.gov (Jay Wattenberg)
FDA MedWatch
http://www.fda.gov/ucm/groups/fdagov-public/documents/image/ucm052224.gif
http://www.fda.gov/Safety/MedWatch/default.htm
144
52
FDA MedWatch Safety Alerts
Tygacil (tigecycline): Label Change - Increased Mortality Risk
Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.
Wed, 01 Sep 2010 10:00:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224626.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224626.htm
Huber Needles: Recall - Risk of Coring
Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient’s lungs.
Thu, 26 Aug 2010 15:40:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224163.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224163.htm
Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens
Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices.
Thu, 26 Aug 2010 14:30:00 -0400
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224135.htm
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224135.htm
TimeOut Capsules: Undeclared Drug Ingredient
Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil
|